(NYSE:HOV), Met or Exceeded All Guidance Metrics Provided8% Year-Over-Year Increase in Consolidated CommunitiesSuccessfully Completed $900 Million Unsecured Debt Refinancing Extending Maturities Until 2031 and 2033Operating Performance Reflects a $34 Million Expense from Refinancing and $19 Million in Land Charges MATAWAN, N.J., Dec. 04, 2025 (GLOBE NEWSWIRE) — Hovnanian Enterprises, Inc. (NYSE: HOV), a leading national […]

(NASDAQ:JTAI), Las Vegas, NV, Dec. 04, 2025 (GLOBE NEWSWIRE) — Jet.AI Inc. (“Jet.AI”) (Nasdaq: JTAI), an emerging provider of high-performance GPU infrastructure and AI cloud services, and Convergence Compute LLC (“Convergence Compute”), Jet.AI's joint venture with Consensus Core Technologies Inc. (“Consensus Core”), today announced the selected location for Convergence Compute's Midwestern Canadian data-center campus, a

Hovnanian Enterprises Reports Fourth Quarter and Fiscal Year 2025 Results GlobeNewswire December 04, 2025 Met or Exceeded All Guidance Metrics Provided8% Year-Over-Year Increase in Consolidated CommunitiesSuccessfully Completed $900 Million Unsecured Debt Refinancing Extending Maturities Until 2031 and 2033Operating Performance Reflects a $34 Million Expense from Refinancing and $19 Million in Land Charges MATAWAN, N.J., Dec.

BeautyHealth Releases Third Annual Skintuition Report Latest volume reveals how shifting consumer preferences are redefining modern aesthetics GlobeNewswire December 04, 2025 LONG BEACH, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) — The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today released Volume Three of its Skintuition Report, an annual deep dive into the

Jet.AI & Consensus Core Announce Strategic Interest in Midwestern Canadian Data-Center Campus GlobeNewswire December 04, 2025 Las Vegas, NV, Dec. 04, 2025 (GLOBE NEWSWIRE) — Jet.AI Inc. (“Jet.AI”) (Nasdaq: JTAI), an emerging provider of high-performance GPU infrastructure and AI cloud services, and Convergence Compute LLC (“Convergence Compute”), Jet.AI's joint venture with Consensus Core Technologies Inc.

Enterololin uses a novel mechanism of action to attack the infection.New treatment has potential use in Crohn’s Disease.License is under existing Research and Collaboration Agreement with McMaster. Hamilton, Ontario–(Newsfile Corp. – December 4, 2025) – Stoked Bio Inc., a Canadian biotechnology company focused on the development of novel anti-infectives and cancer therapeutics, announced today it

The 2026 ISPE Facilities of the Future Conference will take place from 2-3 February 2026 inSan Diego, California, United States, and virtually. The International Society for Pharmaceutical Engineering (ISPE) has announced its keynote speakers for the 2026 ISPE Facilities of the Future Conference, set for Monday, 2 February, through Tuesday, 3 February, in San Diego,

DALLAS, Dec. 04, 2025 (GLOBE NEWSWIRE) — MODE Global is proud to announce it has been named a 2025 Top 50 Leading 3PL by Global Trade. MODE was last included in the 2023 list in the intermodal category. Announced in the December issue of Global Trade, the list was broken into seven categories including Tech

MODE Global Named a 2025 Top 50 Leading 3PL by Global Trade Magazine GlobeNewswire December 04, 2025 DALLAS, Dec. 04, 2025 (GLOBE NEWSWIRE) — MODE Global is proud to announce it has been named a 2025 Top 50 Leading 3PL by Global Trade. MODE was last included in the 2023 list in the intermodal category.

Calgary, Alberta–(Newsfile Corp. – December 4, 2025) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”), a leader in autologous stem cell therapeutics for ischemic diseases, is pleased to announce the appointment of Shaune Harding, OStJ, RN non-practicing, as Director of Patient Care & Clinical Operations. In this senior clinical role,